John Gustofson, MSc, MBA, is a business leader with more than two decades of experience ranging from business development and venture investing to operational experience across multiple startup biotech and global pharmaceutical companies.
Mr. Gustofson is currently Managing Director of AbbVie Biotech Ventures. He also served as Senior Director of Venture Investments & Early Stage Collaborations for AbbVie, where he identified and transacted venture and early stage opportunities across therapy areas including immunology, oncology, virology, renal disease, and neuroscience. Prior to joining AbbVie, Mr. Gustofson worked at AstraZeneca as a Director of Strategic Partnering and Business Development. Additionally, he has nearly 20 years’ experience as a bench scientist and has served in various roles of market and business development. He has worked for numerous biotechnology companies including Altus Pharmaceuticals and Therion Biologics and also served as a strategy consultant for the life sciences industry. Mr. Gustofson serves on the board of Ribometrix and is a board observer for Disarm Therapeutics and Ribon Therapeutics
He holds a bachelor’s degree in microbiology from Western Illinois University, a master’s degree in molecular biology from Miami University, and a Master of Business Administration from Boston University.